Skip to Content


In the US, Perampanel (perampanel systemic) is a member of the drug class AMPA receptor antagonists and is used to treat Epilepsy and Seizures.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiepileptic agent

Treatment of Parkinson's disease

Chemical Name

2-(6'-oxo-1'-phenyl-1',6'-dihydro[2,3'-bipyridin]-5'-yl)benzonitrile (WHO)

Foreign Names

  • Perampanelum (Latin)
  • Perampanel (German)
  • PĂ©rampanel (French)
  • Perampanel (Spanish)

Generic Names

  • Perampanel (OS: USAN, BAN)
  • E2007 (IS)
  • ER-155055-90 (IS)
  • UNII-H821664NPK (IS)

Brand Names

  • Fycampa
    Eisai Farmaceutica, Spain
  • Fycompa
    Eisai, Austria; Eisai, Belgium; Eisai, Canada; Eisai, Germany; Eisai, Denmark; Eisai, Finland; Eisai, France; Eisai, United Kingdom; Eisai, Hong Kong; Eisai, Ireland; Eisai, Israel; Eisai, Iceland; Eisai, Lithuania; Eisai, Latvia; Eisai, Malaysia; Eisai, Poland; Eisai, Sweden; Eisai, United States; Eisai Farmaceutica, Spain; Eisai Ltd., Norway; Eisai Pharma, Switzerland


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.